| Alternative mechanisms of miR-34a regulation in cancer E Slabáková, Z Culig, J Remšík, K Souček Cell death & disease 8 (10), e3100-e3100, 2017 | 244 | 2017 |
| Exacerbation of substrate toxicity by IPTG in Escherichia coli BL21(DE3) carrying a synthetic metabolic pathway P Dvorak, L Chrast, PI Nikel, R Fedr, K Soucek, M Sedlackova, ... Microbial cell factories 14, 1-15, 2015 | 231 | 2015 |
| ZEB1: a critical regulator of cell plasticity, DNA damage response, and therapy resistance S Drápela, J Bouchal, MK Jolly, Z Culig, K Souček Frontiers in molecular biosciences 7, 36, 2020 | 117 | 2020 |
| TGF‐β1‐induced EMT of non‐transformed prostate hyperplasia cells is characterized by early induction of SNAI2/Slug E Slabáková, Z Pernicová, E Slavíčková, A Staršíchová, A Kozubík, ... The prostate 71 (12), 1332-1343, 2011 | 104 | 2011 |
| The comparison of impedance-based method of cell proliferation monitoring with commonly used metabolic-based techniques L Vistejnova, J Dvorakova, M Hasova, T Muthny, V Velebny, K Soucek, ... Neuroendocrinology Letters 30 (1), 121, 2009 | 103 | 2009 |
| Normal and prostate cancer cells display distinct molecular profiles of α‐tubulin posttranslational modifications K Souček, A Kamaid, AD Phung, L Kubala, JC Bulinski, RW Harper, ... The Prostate 66 (9), 954-965, 2006 | 100 | 2006 |
| Growth/differentiation factor-15: prostate cancer suppressor or promoter? P Vaňhara, A Hampl, A Kozubík, K Souček Prostate cancer and prostatic diseases 15 (4), 320-328, 2012 | 85 | 2012 |
| High effectiveness of platinum (IV) complex with adamantylamine in overcoming resistance to cisplatin and suppressing proliferation of ovarian cancer cells in vitro A Kozubík, V Horváth, L Švihálková-Šindlerová, K Souček, J Hofmanová, ... Biochemical pharmacology 69 (3), 373-383, 2005 | 83 | 2005 |
| The fibroblast surface markers FAP, anti‐fibroblast, and FSP are expressed by cells of epithelial origin and may be altered during epithelial‐to‐mesenchymal transition Z Kahounová, D Kurfürstová, J Bouchal, G Kharaishvili, J Navrátil, ... Cytometry Part A 93 (9), 941-951, 2018 | 76 | 2018 |
| Inhibition of topoisomerase IIα: novel function of wedelolactone P Benes, L Knopfova, F Trcka, A Nemajerova, D Pinheiro, K Soucek, ... Cancer letters 303 (1), 29-38, 2011 | 76 | 2011 |
| Trop2: Jack of all trades, master of none S Lenárt, P Lenárt, J Šmarda, J Remšík, K Souček, P Beneš Cancers 12 (11), 3328, 2020 | 72 | 2020 |
| Drug efflux transporters, MRP1 and BCRP, affect the outcome of hypericin-mediated photodynamic therapy in HT-29 adenocarcinoma cells R Jendželovský, J Mikeš, K Souček, J Procházková, M Kello, V Sačková, ... Photochemical & Photobiological Sciences 8 (12), 1716-1723, 2009 | 72 | 2009 |
| c-Myb regulates matrix metalloproteinases 1/9, and cathepsin D: implications for matrix-dependent breast cancer cell invasion and metastasis L Knopfová, P Beneš, L Pekarčíková, M Hermanová, M Masařík, ... Molecular cancer 11, 1-15, 2012 | 69 | 2012 |
| Rottlerin Inhibits ROS Formation and Prevents NF B Activation in MCF-7 and HT-29 Cells E Maioli, L Greci, K Soucek, M Hyzdalova, A Pecorelli, V Fortino, ... BioMed Research International 2009, 2009 | 66 | 2009 |
| Effect of apple extracts on NF-κB activation in human umbilical vein endothelial cells PA Davis, JA Polagruto, G Valacchi, A Phung, K Soucek, CL Keen, ... Experimental Biology and Medicine 231 (5), 594-598, 2006 | 63 | 2006 |
| Gene expression changes in human prostate carcinoma cells exposed to genotoxic and nongenotoxic aryl hydrocarbon receptor ligands E Hrubá, J Vondráček, H Líbalová, J Topinka, V Bryja, K Souček, ... Toxicology letters 206 (2), 178-188, 2011 | 56 | 2011 |
| T umor suppressor candidate 3 (TUSC3) prevents the epithelial‐to‐mesenchymal transition and inhibits tumor growth by modulating the endoplasmic reticulum stress response in … K Kratochvílová, P Horak, M Ešner, K Souček, D Pils, M Anees, ... International journal of cancer 137 (6), 1330-1340, 2015 | 55 | 2015 |
| Growth/differentiation factor-15 inhibits differentiation into osteoclasts—A novel factor involved in control of osteoclast differentiation P Vaňhara, E Lincová, A Kozubík, P Jurdic, K Souček, J Šmarda Differentiation 78 (4), 213-222, 2009 | 51 | 2009 |
| Rottlerin inhibits the nuclear factor κB/Cyclin-D1 cascade in MCF-7 breast cancer cells C Torricelli, V Fortino, E Capurro, G Valacchi, A Pacini, M Muscettola, ... Life sciences 82 (11-12), 638-643, 2008 | 51 | 2008 |
| Different modulation of TRAIL-induced apoptosis by inhibition of pro-survival pathways in TRAIL-sensitive and TRAIL-resistant colon cancer cells A Vaculová, J Hofmanová, K Souček, A Kozubík FEBS letters 580 (28-29), 6565-6569, 2006 | 51 | 2006 |
